# Study of Wafermine™ for Post-bunionectomy or Abdominoplasty Pain

> **NCT03246971** · PHASE2 · COMPLETED · sponsor: **iX Biopharma Ltd.** · enrollment: 125 (actual)

## Conditions studied

- Acute Pain
- Bunion
- Abdominoplasty

## Interventions

- **DRUG:** Wafermine™ 50 mg
- **DRUG:** Wafermine™ 75 mg
- **DRUG:** Placebos
- **DRUG:** Wafermine™ 25 mg

## Key facts

- **NCT ID:** NCT03246971
- **Lead sponsor:** iX Biopharma Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-24
- **Primary completion:** 2018-07-12
- **Final completion:** 2018-07-17
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2018-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03246971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03246971, "Study of Wafermine™ for Post-bunionectomy or Abdominoplasty Pain". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03246971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*